Currently, the field of radiation therapy is changing in terms of radiation type, and there are several changes in adoption patterns among its end-user segments. The end users are shifting from conventional radiation (Xray, or Cobalt-60, among others) to modern radiation such as a proton or heavy ion radiation. The increasing demand for modern radiation therapy systems has led to the increasing awareness of cancer/tumor treatments. The primary role of these systems is to shrink or destroy cancer/tumor depending on cancer/tumor type, stage, patient age, number of radiation sessions required, and many other factors. Radiation therapy can be divided primarily into external beam radiation therapy, also known as teletherapy, and internal beam radiation therapy, also known as brachytherapy. In the past decade, the definition of these technologies has expanded. Earlier the radiation therapy was only referred to as a simple therapy only done by the radiation beam. Now, radiation therapy includes internal radiation or external radiation combined with chemotherapy or open body surgery or combining various radiation therapy techniques such as IGRT, VMAT, and SRS to destroy or shrink cancer/ tumor. The ongoing trend of offering new radiation therapy systems which have proton or heavy ion beam, integration of two different radiation therapies, and integration of imaging technology with radiation therapy systems showcase the growing future of technological innovations and advancements in radiation therapy in the oncology field.

1. Market Definition 

2. Markets

3. Application

4. Products

5. Region

6. Markets - Competitive Benchmarking & Company Profiles

7. Research Methodology